» Articles » PMID: 32996061

LncRNA H19 Inhibits the Progression of Sepsis-Induced Myocardial Injury Via Regulation of the MiR-93-5p/SORBS2 Axis

Overview
Journal Inflammation
Date 2020 Sep 30
PMID 32996061
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis is an infectious disease that seriously endangers human health. It usually leads to myocardial injury which seriously endangers to the health of human beings. H19 has been confirmed to play key roles in various diseases, including sepsis. However, its function in the progression of sepsis-induced myocardial injury remains largely unknown. H9C2 cells were treated with lipopolysaccharide (LPS) to mimic sepsis-induced myocardial injury in vitro. Cell proliferation and apoptosis were detected by MTT assay and flow cytometry, respectively. In addition, gene and protein expression levels in H9C2 cells were measured by quantitative real-time PCR (qRT-PCR) and Western blotting. The levels of inflammatory cytokines in H9C2 cell supernatants were tested by ELISA. JC-1 staining was performed to observe the mitochondrial membrane potential level in H9C2 cells. H19 and SORBS2 were downregulated in H9C2 cells following LPS treatment, while miR-93-5p was upregulated. Moreover, LPS-induced cell growth inhibition and mitochondrial damage were significantly reversed by overexpression of H19. In addition, H19 upregulation notably suppressed LPS-induced inflammatory responses in H9C2 cells. Moreover, H19 sponged miR-93-5p to promote SORBS2 expression. Overall, H19 suppressed sepsis-induced myocardial injury via regulation of the miR-93-5p/SORBS2 axis. H19 attenuated the development of sepsis-induced myocardial injury in vitro via modulation of the miR-93-5p/SORBS2 axis. Thus, H19 could serve as a potential target for the treatment of sepsis-induced myocardial injury.

Citing Articles

MicroRNAs as regulators of cardiac dysfunction in sepsis: pathogenesis and diagnostic potential.

Liu Z, Li F, Li N, Chen Y, Chen Z Front Cardiovasc Med. 2025; 12:1517323.

PMID: 40041174 PMC: 11876399. DOI: 10.3389/fcvm.2025.1517323.


Revealing Landscape of Competing Endogenous RNA Networks in Sepsis-Induced Cardiovascular Diseases.

Xiong W, Feng S, Zhao Y, Liu X, Gong J Rev Cardiovasc Med. 2024; 24(7):214.

PMID: 39077015 PMC: 11266464. DOI: 10.31083/j.rcm2407214.


Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy.

Kuroshima T, Kawaguchi S, Okada M Int J Mol Sci. 2024; 25(9).

PMID: 38731929 PMC: 11083471. DOI: 10.3390/ijms25094710.


LncRNA H19: a novel player in the regulation of diabetic kidney disease.

Wu Q, Huang F Front Endocrinol (Lausanne). 2023; 14:1238981.

PMID: 37964955 PMC: 10641825. DOI: 10.3389/fendo.2023.1238981.


Emerging roles of microRNAs in septic cardiomyopathy.

Wu M, Li G, Wang W, Ren H Front Pharmacol. 2023; 14:1181372.

PMID: 37475718 PMC: 10354437. DOI: 10.3389/fphar.2023.1181372.


References
1.
Prescott H, Cope T, Gesten F, Ledneva T, Friedrich M, Iwashyna T . Reporting of Sepsis Cases for Performance Measurement Versus for Reimbursement in New York State. Crit Care Med. 2018; 46(5):666-673. PMC: 5899037. DOI: 10.1097/CCM.0000000000003005. View

2.
Faix J . Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013; 50(1):23-36. PMC: 3613962. DOI: 10.3109/10408363.2013.764490. View

3.
Rello J, Valenzuela-Sanchez F, Ruiz-Rodriguez M, Moyano S . Sepsis: A Review of Advances in Management. Adv Ther. 2017; 34(11):2393-2411. PMC: 5702377. DOI: 10.1007/s12325-017-0622-8. View

4.
Muret K, Klopp C, Wucher V, Esquerre D, Legeai F, Lecerf F . Long noncoding RNA repertoire in chicken liver and adipose tissue. Genet Sel Evol. 2017; 49(1):6. PMC: 5225574. DOI: 10.1186/s12711-016-0275-0. View

5.
Wu Z, Trenner M, Boon R, Spin J, Maegdefessel L . Long noncoding RNAs in key cellular processes involved in aortic aneurysms. Atherosclerosis. 2019; 292:112-118. PMC: 6949864. DOI: 10.1016/j.atherosclerosis.2019.11.013. View